Member Info for tomvisual

Steadyeddyguy, thats why I am waiting till Monday, when equilibrium is established and I can see what the impact of an additional 3B shares has on my investment.
I may be wrong, but happier to wait on the sidelines.
A -18% down day may confirm my hypothesis?
As always DYOR.
GLA.

Expru200, lets see where the share price opens tomorrow. The placing shares (1.923B) hit the market tomorrow!
Lets see if the share price is up or down!
Time will tell.
Then, 1.1B consolidation hit the market on Monday!

Please DYOR!!
I am waiting to see where the balance point is on Monday. Then I am happier with an investment here!

Equilibrium (as of Monday) is around 0.08p. Hence, the drop!

Read the last RNS.
3B shares are due to hit the market in the next 2 sessions!
Calculate what the share price us with around 11.8B as opposed to 8.714B (as if today)!

Y4KBS, with the placing and consolidation shares hitting the market Friday and Monday, 0.08p is more likely rather than 0.07p, based on share distribution.
Willing to wait on the sidelines until the placing and consolidation shares hit the market and the real impact is apparent!!

Erfreh, good call!
45p would be a nice holding price as we wait for Project Milestones for next phase over the forthcoming months! GLA

Carl's test - Speed (tick), Sensitivity (tick), Specificity (tick)
Test, test, test

Landy7, on Vela, I calculated what share price is needed to offset placing and consolidated shares due to trade over the next few days. Big increase in share price necessary, so invested here.

The positive is that you are invested here!

Mornington Oz, again many thanks for your tip here!

Kainos, interesting comment from Carl!
What I do know (as a shareholder in Avacta):
1. MHRA Guidelines
Acceptable Sens > 80%, Spec > 95%
Desired Sens > 97%, Spec > 99%

https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/895745/TPP_Point_of_Care_SARS-CoV-2_Detection_Tests.pdf

2.Sona Nanotech initially declared for their LFT a externally validated sensitivity of 96% and specificity of 96%. Reasonable performance against MHRA guidelines. However, during clinical evaluation of their LFT, the figures dropped to 84.6% for sensitivity and 90% for specificity!
https://investingnews.com/daily/life-science-investing/biotech-investing/sona-nanotech-announces-clinical-evaluation-study-results-for-its-covid-19-antigen-test/
In simple terms, wrt MHRA Guidelines, not good enough!!

3. Avacta promised a LFT mid Summer. To date, NO sensitivity and NO specificity information has been officially released. NO in-house,
NO independent and NO clinical validation sensitivity and specificity data has been released. Why?? Someone, claiming to be a former employee at Avacta, stated on the AVCT BB, that manufacture of a LFT is difficult. The slightest Production variation causes a marked change in Sensitivity and Specificity performance outcome of the test! Is this the reason, Avacta have deferred release until Q1 2021? Who knows? (Probably the MMs - LOL!!!)? However, a delay is a delay and Q1 2021 just happens to be when Carl's test is available for roll-out!

4. Avacta's CEO (Dr AS) has stated that no one Company has the capacity to supply the covid test demand. Hence, my statements on this BB that no one supplier will have a monopoly. Essentially, all good tests are needed.
However, some tests will inherently have better clinical performance.
Carl's test is very fast (tick), sensitive (tick) and specific (tick). Listen to the Proactive interview:
https://m.youtube.com/watch?v=-M0O-JFoFUc

Carl's background, tells me he knows his stuff! He is not some Aim CEO wanting your money!!
In Carl we trust, was a title of one of the threads on this BB. Well, for me the POC outcome and my investment was always binary. So I am willing to become a LTH!
"Trust in the force" springs to mind. If everything works out we have a multi bagger here based on market cap.
Worth being a LTH in BRH?? Absolutely!!
Hold for gold!
DYOR!

Carl's test - Speed (tick), Sensitivity (tick), Specificity (tick)
Test, test, test

Jodrell, no one knows what the future brings!
Is the country bankrupt that it cannot afford £100B war chest for covid? Before covid all government budgets were being cut.
Is herd immunity on the cards?
Will local lockdowns create a revolution?
Who knows?? No-one!
What I do know is :
1.RMS are getting the antiviral mask business, but BRH retain a stake in RMS
2. Carl has stated a test will be ready in about 5 months time (Spring 21).
Well if LTHs have to sit and wait 5 months, then why not take the opportunity to drop the share price and generate more turnover of shares due to impatient holders?
Is that what we would all do, N'est pas?Absolutely.
However, nothing is static.
If news leaks and we have the best in class test in terms of speed, sensitivity and specificity which when combined with pooled testing provides a mass test solution that overcomes all of the time delays associated with PCR and all the nuances associated with a LFT test solution (where the slightest of changes can impact test outcome) , then quite simply the share price here will rocket.
We have potentially a great covid test which looks to be able to be amended to address other pathogens.
For covid, no one supplier has a monopoly.
All tests are required!! Demand outstrips supply.
Nothing else will matter as economies cannot move forward.
China has shown the way.
China has recently tested 9 million people in 5 days and isolated infected individuals in bespoke confined areas. Not something other countries can replicate at this moment in time!!
This pandemic us all about testing
Test, test, test

Cyrox,
looking at the chart, short term SMAs tracking downwards.
Can now see trading sideways, bound by SMA20 at 35p and 28p. Plenty of time to wait now!
What moves this from a trading range? NEWS!
Expect 5th Nov update on RMS to result in further downward pressure!
DYOR!
Reverse psychology in play!
FOMO will push this higher, when the time is right.

Carl's test - Speed (tick), Sensitivity (tick), Specificity (tick)
Test, test, test

So, how good are some of these LFT devices?
Well https://www.medrxiv.org/content/10.1101/2020.10.15.20213108v1

Tells me that this variant has a pooled sensitivity of 92% and a specificity of 86.2%.
Implications being you still have to use a PCR test!
"However,our results indicate it would not completely replace the need to conduct a confirmatory laboratory test in certain cases."

Oh dear! Some of these "holy grail" tests appear to depend on prevalence and a confirmatory PCR test! No doubt this adds to test time for results!!
Rethink necessar methinks!!

Carl's test - Tick, tick, tick
Test, test, test

Haha,
Also the so called LFT are specific but not sensitive. So even here, our test is complementary!!
Speed is the key!
Speed is everything!
We have a very fast test (tick), a sensitive test (tick) and a specific test (tick)!!
Tick, tick, tick.
GLA. Hold for gold!

Test, test, test

So was bounce from Zak Mirs SMA34?
It looks to have been the case!
Well done Zak!

Looking at the Technical Chart ...
Present price nearto SMA34, Zak uses this value in his chart analysis!
SMA50 around 26.2.
SMA100 around 21.
Lower Bollinger Band around 20.
Which technical price level do we bounce at??
OR do we need news?
RNS outlining next stage Project Milestones perhaps?
Time will tell, time will tell.

Test, test, test

Haha, well we know that Carl's covid19 test will now accelerate the scientific community to use the "light-switch effect" in other cash generative areas of research!
Market cap is amazingly low for a covid19 stock.
Now other pathogen testing!!
Test, test, test

Researching....
https://www.youtube.com/watch?v=-M0O-JFoFUc

Perhaps Carl in his Proactive interview, is indeed close to the mark on other pathogen testing?

Read Carl's technical papers at  https://pubmed.ncbi.nlm.nih.gov/?term=Carl+Smythe

Several technical papers mention "a luminescence "switch on" DNA light-switch effect.
The principle of a "light-switch effect" is what we appear to have developed here in the Paraytec/Sheffield University covid19 test.
Furthermore, the principle has been shown to have applications to other pathogen testing!!
We are indeed on an interesting journey here!
Hold for gold!
Test, test, test

Orion10, there are 3 drilling programs planned in 2020, Sept, Nov, Dec.
Is your estimate of 12p only on the first drilling program?

Carl's proactive interview
https://www.youtube.com/watch?v=-M0O-JFoFUc

Test,test,test